Keimyung Med J.
2015 Dec;34(2):127-132. 10.0000/kmj.2015.34.2.127.
Pulmonary Mucormycosis Treated Successfully with Posaconazole as Salvage Therapy
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea. wonylee@yonsei.ac.kr
- KMID: 2224175
- DOI: http://doi.org/10.0000/kmj.2015.34.2.127
Abstract
- Mucormycosis (formerly known as zygomycosis) is a life-threatening opportunistic mycosis that infects a broad range of hosts with qualitative or quantitative defects in innate immunity. The overall mortality rate of pulmonary mucormycosis is above 70%. The prognosis and outcome of pulmonary mucormycosis have not improved significantly over the last decade, mainly because of difficulty in early diagnosis and the limited activity of current antifungal agents against members of the order Mucorales. We report a case of pulmonary mucormycosis treated successfully with posaconazole as salvage therapy. We suggest that posaconazole may be considered as an alternative therapeutic approach in patients with invasive pulmonary mucormycosis who are unable to tolerate surgical treatment.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Rhino-Orbital-Cerebral Mucormycosis Successfully Treated by Surgical Treatment and Posaconazole
- A case of successful posaconazole salvage therapy for rhinocerebral mucormycosis after failure of amphotericin B
- Successful Treatment of Rhino-Orbital Mucormycosis with Posaconazole after Combination of Surgical Treatment and Amphotericin B
- Fatal Breakthrough Mucormycosis in an Acute Myelogenous Leukemia Patient while on Posaconazole Prophylaxis
- Posaconazole Treatment in Korea: Single-Center Experience Over 5 Years
